Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Dec 1;14(6):1020-1022.
doi: 10.21037/hbsn-2025-550. Epub 2025 Nov 25.

Rethinking resectability: the case for neoadjuvant treatment in resectable pancreatic cancer

Kai Tai Derek Yeung  1 , Ricky Harminder Bhogal  1   2
Affiliations
Editorial

Rethinking resectability: the case for neoadjuvant treatment in resectable pancreatic cancer

Kai Tai Derek Yeung et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Pancreatic ductal adenocarcinoma; chemotherapy; neoadjuvant treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2025-550/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Schwarz L, Bachet JB, Meurisse A, et al. Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study). J Clin Oncol 2025;43:1984-96. 10.1200/JCO-24-01378 - DOI - PubMed
    1. DePeralta DK, Ogami T, Zhou JM, et al. Completion of adjuvant therapy in patients with resected pancreatic cancer. HPB (Oxford) 2020;22:241-8. 10.1016/j.hpb.2019.07.008 - DOI - PMC - PubMed
    1. Anteby R, Blaszkowsky LS, Hong TS, et al. Disparities in Receipt of Adjuvant Therapy After Upfront Surgical Resection for Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 2023;30:2473-81. 10.1245/s10434-022-12976-1 - DOI - PubMed
    1. Poiraud C, Lenne X, Bruandet A, et al. Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study. World J Surg Oncol 2024;22:123. 10.1186/s12957-024-03393-7 - DOI - PMC - PubMed
    1. Yeung KTD, Kumar S, Cunningham D, et al. Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Adenocarcinoma. Ann Surg Open 2024;5:e486. 10.1097/AS9.0000000000000486 - DOI - PMC - PubMed